ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,718.57
      0.28%
      US Tech 100
      19,312.80
      0.08%
      Dow Jones
      42,124.65
      0.15%
      Brent Oil
      73.69
      -0.06%
      Bitcoin
      62,860.47
      -0.74%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Celyad Oncology SA (CYAD) Quote

      Celyad Oncology SA

      Celyad Oncology SA (CYAD)

      Celyad Oncology SA
      0.47
      0.00
      (0.00%)
      Closed September 23 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      0.47
      Bid
      0.47
      Ask
      0.52
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      19.472M
      Previous Close
      0.47
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      41,429,000
      Dividend Yield
      -
      PE Ratio
      -1.28
      Earnings Per Share (EPS)
      -0.2
      Revenue
      102k
      Net Profit
      -8.45M

      About Celyad Oncology SA

      Celyad Oncology is a biopharmaceutical company, specialized in cell therapy. It develops technologies and treatments to treat severe diseases with poor prognosis. The company focuses on Immuno Oncology, Cardiology, and Medical devices. Its main product candidates include CAR-T and C-Cure. The firm h... Celyad Oncology is a biopharmaceutical company, specialized in cell therapy. It develops technologies and treatments to treat severe diseases with poor prognosis. The company focuses on Immuno Oncology, Cardiology, and Medical devices. Its main product candidates include CAR-T and C-Cure. The firm has CYAD-01 and CYAD-02 programs in the pipeline. The company owns trademarks and service marks including CELYAD, C-CATH, C_CURE, CATH and C-CATHez and CARDIO 3 BIOSCIENCES. The firm has Cardiology and Immuno-oncology operating segments. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.celyad.com
      Headquarters
      Mont-saint-guibert, Walloon Brabant, Bel
      Founded
      -
      Celyad Oncology SA is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CYAD. The last closing price for Celyad Oncology was $0.47. Over the last year, Celyad Oncology shares have traded in a share price range of $ 0.00 to $ 0.00.

      Celyad Oncology currently has 41,429,000 shares outstanding. The market capitalization of Celyad Oncology is $19.47 million. Celyad Oncology has a price to earnings ratio (PE ratio) of -1.28.

      Ask ADVFN Intelligence (AI)

      CYAD Latest News

      More News

      Celyad Oncology annonce la nomination de Matt Kane au poste de CEO

      Regulatory News: Celyad Oncology SA (Euronext & Nasdaq : CYAD) (la « Société » ou « Celyad ») est heureuse d’annoncer la nomination de Matt Kane au poste de Directeur Général (Chief...

      September 16 2024
      Business Wire

      Celyad Oncology Reports First Half Year 2024 Financial Results and Recent Business Highlights

      The Company continues to bolster its intellectual property estate and to pursue options to monetize it The Company’s two main research and development platforms have delivered proof-of-concept...

      September 13 2024
      Business Wire

      Celyad Oncology Reports Full Year 2023 Financial Results and Recent Business Highlights

      Regulatory News: Celyad Oncology (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (the “Company”), today announces its financial results for the fiscal year 2023 ended December 31, 2023, and provides a...

      April 04 2024
      Business Wire

      Celyad Oncology annonce son intention de mettre fin à ses obligations de déclaration à la SEC

      Regulatory News: Celyad Oncology SA (Euronext: CYAD) (« Celyad Oncology » ou la «Société») annonce que la Société déposera volontairement un Formulaire 15F auprès de la Securities and Exchange...

      February 08 2024
      Business Wire

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      January 17 2024
      Edgar (US Regulatory)

      Celyad Oncology fait le point sur les activités du quatrième trimestre 2023 et présente ses perspectives pour 2024

      Trois piliers principaux pour libérer le potentiel des plateformes technologiques propriétaires et de la propriété intellectuelle : Une plateforme technologique exclusive sans édition de génome...

      January 16 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000DR
      40000000DR
      120000000DR
      260000000DR
      520000000DR
      1560000000DR
      2600000000DR

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      KAVLKaival Brands Innovations Group Inc
      $ 1.33
      (129.71%)
      		182.45M
      LASELaser Photonics Corporation
      $ 18.8671
      (81.24%)
      		13.54M
      TGLTreasure Global Inc
      $ 1.18
      (73.45%)
      		139.93M
      NVVENuvve Holding Corporation
      $ 6.68
      (70.41%)
      		31.34M
      UXINUxin Ltd
      $ 2.42
      (52.68%)
      		18.24M
      ELABElevai Labs Inc
      $ 0.10545
      (-62.34%)
      		23.66M
      ADTXAditxt Inc
      $ 0.262
      (-31.52%)
      		3.17M
      FRGTFreight Technologies Inc
      $ 0.081
      (-28.82%)
      		26.36M
      ANEBAnebulo Pharmaceuticals Inc
      $ 2.23
      (-27.60%)
      		113.78k
      STSSSharps Technology Inc
      $ 0.1722
      (-27.06%)
      		2.27M
      XPONExpion360 Inc
      $ 0.1144
      (34.91%)
      		432.14M
      NVDANVIDIA Corporation
      $ 116.26
      (0.22%)
      		206.23M
      INTCIntel Corporation
      $ 22.56
      (3.30%)
      		184.43M
      KAVLKaival Brands Innovations Group Inc
      $ 1.33
      (129.71%)
      		182.45M
      TGLTreasure Global Inc
      $ 1.18
      (73.45%)
      		139.93M

      Discussion

      View Full Feed
      Brianwhi Brianwhi 2 minutes ago
      Basement dwellers
      DJT
      Genz2 Genz2 3 minutes ago
      https://www.businessinsider.com/mark-cuban-donald-trump-silver-coins-bitcoin-investing-metals-election-2024-9

      Why doesn’t Trump make things easier for himself? He could endorse a coin that has a big letter ‘B’ on one side and then a portrait of himself on the other side!! That could
      norisknorewards norisknorewards 3 minutes ago
      Anyone? Why unblind early?
      NWBO
      mike_dotcom mike_dotcom 3 minutes ago
      Forget it, it'll disappear just like the PDD data into the dustbin of history never to be heard from again. And then they will focus on 371 for the next decade.
      PDD
      fnyack fnyack 3 minutes ago
      Shib is on a plane headed South, I mean the South Pole, it’s going on ice.
      SHIBUSD
      mascale mascale 4 minutes ago
      Also noting that IHUB has no genetic records of mascale heritage details.
      HIRU
      bigstocksnbonds bigstocksnbonds 4 minutes ago
      A month to go wow—- way to go!!!!!
      Kjv Kjv 4 minutes ago
      Oh okay
      HQGE
      Atlanta1 Atlanta1 6 minutes ago
      The 10Q comment was in specific reference to the decision to shutdown the armor plant.
      SINT
      TomFromYahoo TomFromYahoo 6 minutes ago
      Well, it's been almost three weeks since the latest S-1, and... nothing. I have to assume that the latest attempt at an IPO has failed just like the others. But, given this company's outstanding recent history of shareholder relations, who knows.... certainly not the shareholders.
      tdbowieknife tdbowieknife 7 minutes ago
      Thank you...


      ..


      .
      Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 7 minutes ago
      Zzzzzzzzzzzz...Zzzzzzzzzzzz

      Nothing to see here

      EMA filing, where are you?
      AVXL
      janice shell janice shell 8 minutes ago
      Parnas has something of a teddy bear attraction about him.

      Yes, he does. It was kind of touching that he wanted to apologize to Hunter. I just hope they don't go into business together.
      MrSmith18 MrSmith18 8 minutes ago
      FINRA is overseen by the Securities and Exchange Commission (SEC)... So what is your point? As usual, spewing nonsense...
      SRNW
      ToucanYoucan ToucanYoucan 8 minutes ago
      $TCNT - I guess not. Had pretty high hopes for this one due to the extremely low float and then Management stopped filing their financial statements.

      It hasn't traded in over two years. Last trade: 9/13/22
      https://www.otcmarkets.com/stock/TCNT/security
      TCNT
      sony12 sony12 9 minutes ago
      Imo NO SCAM imo
      IFUS
      TJG TJG 9 minutes ago
      Yea Stiles is VP and he is financing for now and if out side financing is needed it will always be non toxic and non dilutive. Which I take to mean bank or some other interest baring financing.

      So no RS
      No convertible debt
      Ready to announce out side government contract
      PHBI
      Zilla Zilla 11 minutes ago
      Been back in and flipped some calls but now holding shares. Willing to add and have dry powder to do so if it drops again.... Divi gets paid this Wednesday (25th) (1.00) and it's trying to find a new range. I expect a divi cut to .50 but if not this is going to do very well long term with a 30+% div
      IEP
      $5.95akadawson-m $5.95akadawson-m 11 minutes ago
      Well, I believed in Healthsouth and talked it up a lot. Had no idea the CEO was a freaking ********. And Enron - told my friends about it. Many others. It doesn’t matter how much one talks about a scam that is disguised as a bonafide stock does it? We all are snookered. I mean we on this board know
      CYDY
      Jp_SHMP Jp_SHMP 12 minutes ago
      we all know that you sold, this is where is your money

      enjoy chasing
      IGPK
      pinkslipjunkie pinkslipjunkie 12 minutes ago
      Been about a year now for you hasn't it?...I have been here since Feb 2024 or close around that.
      I have been patiently waiting for so long
      EMGE
      Lime Time Lime Time 13 minutes ago
      I tend to study more what makes a stock bullish or bearish, and try to figure out what makes some stocks move. I like to study both sides, bulls and bears. While I study both sides of every circumference of the angles, I do agree with you that this stock is bearish.
      VTXB
      crazy horse 0 crazy horse 0 14 minutes ago
      That is some Video


      Everyone needs to see this! Important!
      https://truthsocial.com/group/q/posts/113175016070327151
      Eli's Gone Eli's Gone 14 minutes ago
      Pretty much a lock he won't lead the league in saves...

      Your Recent History

      NASDAQ
      CYAD
      Celyad Oncology
      Delayed Upgrade Clock